Allergan PLC AGN, -1.
89% shares declined in after-hours trading Wednesday after the pharmaceutical giant announced that a major study of one of its candidates on major depressive disorder did not produce the desired results. Allergan said that three studies of rapastinel showed that the drug did not produce different results from a placebo, and an interim analysis showed that primary and key secondary goals would not be met.
Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Exposure to infection in the womb increases risk of autism and depression, study saysChildren born to women who had a severe infection during pregnancy, such as sepsis, flu or pneumonia, show an increased risk of autism spectrum disorder and depression, according to new research
Read more »
Stocks under pressure | Ex-Nissan CEO post bail | New depression treatment approvedFutures are pointing to a mostly lower open for the Wednesday session, with Wall Street stuck in a mild funk.
Read more »
California’s housing supply law fails to spur enough construction, study saysThe report found that it would take until after the year 3000 for Santa Clara, Irvine, Burbank and many others to achieve their low-income housing targets, assuming current production rates.
Read more »
Stocks retreat after failed Trump-Kim summit; GDP data better than expectedU.S. stocks fall Thursday morning but are off pre-market lows after a reading of fourth-quarter GDP came in better than expected.
Read more »
Global stocks fall for third day as investors dial down trade hopesGlobal stocks retreated for a third straight day on Thursday as investors reduce...
Read more »
Victoria's Secret parent stock falls 8% after mixed Q4 results
Read more »
Square stock falls after mixed outlook overshadows earnings beat
Read more »
South Korean Stocks, Currency Fall After Trump-Kim Summit Ends Without DealSouth Korean stocks slumped in late trading after President Trump and North Korean leader Kim Jong Un ended their summit in Vietnam without an agreement.
Read more »
Salesforce stock falls after earnings and revenue beat
Read more »
An Alphabet spinout announced its first new cybersecurity product, and competitor Splunk's stock fell 5%Splunk's stock dropped 5% after Alphabet's Chronicle, originally spun out of Google's X team, launched a new cybersecurity product called Backstory.
Read more »